Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Quarterly Journal of Nuclear Medicine and Molecular Imaging is Scopus-indexed (Q3, CiteScore 3), WoS SCIE. Published by Edizioni Minerva Medica.
Checked against the index lists dated .
ISSN 1824-4785Verify ISSN ↗1827-1936Verify ISSN ↗
Publisher: Edizioni Minerva Medica
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 183 / 361 | 49th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q3, CiteScore 3.
Quarterly Journal of Nuclear Medicine and Molecular Imaging is Q3 in Radiology, Nuclear Medicine and Imaging (rank 183 of 361), by CiteScore 2025.
Quarterly Journal of Nuclear Medicine and Molecular Imaging is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3, which places it in quartile Q3 at the 49th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.345, quartile Q3, with an H-index of 67.
Quarterly Journal of Nuclear Medicine and Molecular Imaging is published by Edizioni Minerva Medica. Its print ISSN is 1824-4785 and its online ISSN is 1827-1936.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Quarterly Journal of Nuclear Medicine and Molecular Imaging has an h-index of 24 and a 2-year mean of 1.83 citations per paper (OpenAlex). Its Scopus CiteScore is 3, quartile Q3. On 2-year citations it ranks #133 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Quarterly Journal of Nuclear Medicine and Molecular Imaging published 36 papers in 2025; its busiest recent year was 2022 with 66. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2023–2026), authors are most often from Italy (26.4%), France (10.8%) and United States (8.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.